封面
市场调查报告书
商品编码
1375910

子宫内膜消融市场规模、份额、趋势分析报告:依产品、最终用途、地区、细分市场趋势,2023-2030 年

Endometrial Ablation Market Size, Share & Trends Analysis Report By Product (Thermal Balloon, Cryoablation, RFA, Hydrothermal Ablation, Microwave Energy), By End-use (Hospitals, Clinics, ASCs), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

子宫内膜消融市场的成长与趋势:

Grand View Research, Inc.最新报告显示,预计2030年全球子宫内膜去除术市场规模将达到16.9亿美元,2023年至2030年年复合成长率为5.16%。

这种增长归因于妇科疾病盛行率的增加和社会对子宫内膜去除术的认识的提高。根据内分泌学会的数据,PCOS罹患所有育龄妇女的 7% 至 10%,并且是不孕的主要原因。此外,越来越重视提高对妇科癌症的认识,以及子宫肌腺症患者病率的不断上升,特别是在 50 岁以上的女性中,已导致全球范围内子宫内膜切除术的增加。预计将对

根据联合国亚太经社会统计,2020年,在总人口中,60岁以上人口中,女性约占53.2%,80岁以上人口中,约占61.2%。这样,老年女性人口的增加也促进了市场的成长。儘管有有利的成长环境,但与子宫消融手术相关的潜在併发症,例如子宫穿孔、高烧和呼吸急促,可能会稍微阻碍市场动态。此外,子宫内膜移除术(一种手术的微创替代方案)已成为可能,使得在日间手术中当场破坏子宫内膜成为可能。这种方法风险较小,技术上也较容易。

根据国际妇产科联合会 (FIGO) 的数据,异常子宫出血 (AUB) 在全球范围内具有重大影响,育龄妇女的发生率约为 3-30%。预计这将推动整体市场的成长。全球市场相关人员正在采取各种配合措施来提高人们对 AUB 等与女性相关疾病的认识,包括组织社群媒体活动和推出网站。这项策略使企业能够增强能力、提高能力、扩大产品系列。例如,2022 年 8 月,Minerva Surgical 发起了「Time to Talk」社群媒体活动和社群活动系列。这项配合措施将有助于提高 AUB 在世界各地的认识。这项配合措施预计将扩大子宫内膜消融设备的消费者基础,并成为产生收入的驱动力。

子宫内膜去除术市场报告亮点

  • 2022年,由于子宫内膜层移除的射频消融治疗设备的需求不断增加,射频消融治疗(RFA)产品领域主导了市场。
  • 2022年,由于诊所比医院更受青睐子宫内膜去除术,因此诊所细分市场占据主导地位。
  • 由于妇科疾病患者数量的增加、医疗基础设施的改善以及提供尖端子宫内膜消融设备的行业领先公司的强大基础,北美在 2022 年占据了最大的市场份额。
  • 市场参与者正在采取各种策略来扩大自家公司在市场上的覆盖范围并提高不同地区的可用性。

目录

第1章调查方法和范围

第2章执行摘要

第3章子宫内膜移除术市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 子宫内膜移除术市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章子宫内膜移除术市场:产品估算与趋势分析

  • 2018年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的全球子宫内膜去除术市场展望
  • 2023 年至 2030 年市场规模、预测与趋势分析如下

第5章子宫内膜移除术市场:最终用途估计与趋势分析

  • 2018 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 以最终用途分類的全球子宫内膜消融市场展望
  • 2023 年至 2030 年市场规模、预测与趋势分析如下

第6章子宫内膜移除术市场:区域估计与趋势分析

  • 2018 年和 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2023-2030年市场规模及预测趋势分析:
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • 创新者
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2022
    • Medtronic.
    • The Cooper Companies, Inc.
    • Boston Scientific Corporation
    • Johnson &Johnson Service Inc.
    • Olympus Corporation
    • Richard Wolf GmbH.
    • AngioDynamics.
    • Hologic, Inc.
    • Minerva Surgical, Inc.
Product Code: GVR-4-68039-608-0

Endometrial Ablation Market Growth & Trends:

The global endometrial ablation market size is expected to reach USD 1.69 billion by 2030, expanding at a CAGR of 5.16% from 2023 to 2030, based on a new report by Grand View Research, Inc.. This growth can be attributed to the growing prevalence of gynecological disorders and public awareness about endometrial ablation procedures. According to the Endocrine Society, PCOS affects between 7% and 10% of all women of reproductive age and is the foremost cause of infertility, which will certainly contribute to the overall market growth. Furthermore, the increased emphasis on raising awareness of gynecological cancer and the increasing prevalence of adenomyosis in women, especially after the age of 50 years, will have a positive impact on endometrial ablation surgery worldwide.

As per the United Nations ESCAP, out of the total population, around 53.2% of the population aged 60 years and above were women, and around 61.2% of the population aged 80 years and more were women in 2020. Thus, the rise in the geriatric women population also contributes to the market growth. Despite these favorable growth environments, the potential complications connected with uterine ablation surgery, like uterine perforation, high fever, and shortness of breath, may slightly impede market dynamics. Moreover, it has become possible to destroy the endometrium in situ in a day-care procedure due to the availability of minimally invasive endometrial ablation procedures as an alternative to surgeries. This procedure is less risky and technically simple to perform.

According to the International Federation of Gynecology and Obstetrics (FIGO), Abnormal Uterine Bleeding (AUB) in the reproductive years has a significant global impact, with an incidence of around 3 to 30% among reproductive-aged women. Thereby expected to propel the growth of the overall market. The global market players are undertaking various initiatives, such as organizing social media campaigns and launching websites to raise awareness about women-associated diseases, such as the AUB. This strategy enables companies to increase their capabilities, improve their competencies, and expand their product portfolios. For instance, in August 2022, Minerva Surgical, Inc. launched a "Time to Talk" social media campaign and local event series. This initiative will help raise awareness about AUB worldwide. This initiative will increase the consumer base for endometrial ablation devices, driving revenue generation.

Endometrial Ablation Market Report Highlights:

  • In 2022, the radiofrequency ablation (RFA) product segment dominated the market owing to the increased demand for RFA devices for removal of endometrial layers
  • In 2022, the clinics segment dominated the market owing to the increased preference for clinics over hospitals to perform endometrial ablation procedures
  • North America held the largest share in 2022 owing to the rising cases of gynecological disorders, improvement in healthcare infrastructure, and a strong foundation of top industry players to deliver cutting-edge endometrial ablation devices
  • Market players adopt various strategies to increase the reach of their products in the market and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endometrial Ablation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising number of uterine problems
      • 3.2.1.2. Increasing preference towards minimally invasive surgical procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising treatment costs
      • 3.2.2.2. Presence of alternative treatment options
  • 3.3. Endometrial Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Endometrial Ablation Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2018 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Endometrial Ablation Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 4.4.1. Cryoablation
      • 4.4.1.1. Cryoablation market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Radiofrequency Ablation
      • 4.4.2.1. Radiofrequency ablation market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Hydrothermal Ablation
      • 4.4.3.1. Hydrothermal ablation market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Thermal Balloon
      • 4.4.4.1. Thermal balloon market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.5. Microwave Energy
      • 4.4.5.1. Microwave energy market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Endometrial Ablation Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2018 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Endometrial Ablation Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2. Clinics
      • 5.4.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3. Ambulatory Surgical Centers
      • 5.4.3.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Endometrial Ablation Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2018 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive Scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. Medtronic.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. The Cooper Companies, Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Boston Scientific Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Johnson & Johnson Service Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Olympus Corporation
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Richard Wolf GmbH.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. AngioDynamics.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Hologic, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Minerva Surgical, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of regulatory bodies for different countries
  • Table 2 Key companies' product launches
  • Table 3 Key companies' merger and acquisitions
  • Table 4 Key companies' collaboration
  • Table 5 Other strategic initiatives of companies
  • Table 6 North America endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S. endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Europe endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Germany endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 20 France endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 21 France endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Italy endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Spain endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Sweden endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 29 Sweden endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Denmark endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 31 Denmark endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 36 Japan endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 37 China endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 38 China endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 39 India endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 40 India endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 43 South Korea endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 44 South Korea endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Thailand endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 46 Thailand endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Latin America endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Brazil endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 51 Brazil endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Mexico endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 53 Mexico endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Argentina endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Africa endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 63 UAE endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait endometrial ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Endometrial ablation market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement process
  • Fig. 4 Primary research pattern
  • Fig. 5 Endometrial ablation market snapshot, 2022 (USD Million)
  • Fig. 6 Segment snapshot, USD Million
  • Fig. 7 Competitive landscape snapshot
  • Fig. 8 Penetration & growth prospect mapping, by product
  • Fig. 9 Market driver analysis (Current & future impact)
  • Fig. 10 Market restraint analysis (Current & future impact)
  • Fig. 11 Endometrial ablation market, product outlook key takeaways (USD Million)
  • Fig. 12 Endometrial ablation market: Product movement analysis (USD Million), 2022 & 2030
  • Fig. 13 Cryoablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Radiofrequency ablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Hydrothermal ablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Thermal balloon market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Microwave energy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Endometrial ablation market, end use outlook key takeaways (USD Million)
  • Fig. 20 Endometrial ablation market: End use movement analysis (USD Million), 2022 & 2030
  • Fig. 21 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Ambulatory centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Endometrial ablation market: Regional key takeaways (USD Million)
  • Fig. 25 Endometrial ablation market: Regional outlook, 2022 & 2030, USD Million
  • Fig. 26 North America endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Italy endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Japan endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Australia endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 List of key emerging company's/technology disruptors/innovators